Primary |
Depression |
48.9% |
Drug Use For Unknown Indication |
20.9% |
Anxiety |
7.2% |
Hypertension |
2.9% |
Anxiety Disorder |
2.2% |
Panic Attack |
2.2% |
Panic Disorder |
2.2% |
Inflammation |
1.4% |
Injury |
1.4% |
Multiple Myeloma |
1.4% |
Nervousness |
1.4% |
Product Used For Unknown Indication |
1.4% |
Unemployment |
1.4% |
Blood Triglycerides |
0.7% |
Borderline Personality Disorder |
0.7% |
Cardiac Disorder |
0.7% |
Colitis |
0.7% |
Convulsion Prophylaxis |
0.7% |
Epilepsy |
0.7% |
Erectile Dysfunction |
0.7% |
|
Death |
11.4% |
Vomiting |
11.4% |
Tremor |
10.0% |
Weight Increased |
10.0% |
Suicidal Ideation |
7.1% |
Suicide Attempt |
5.7% |
Weight Decreased |
5.7% |
Withdrawal Syndrome |
5.7% |
Surgery |
4.3% |
Tardive Dyskinesia |
4.3% |
Vertigo |
4.3% |
Drug Ineffective |
2.9% |
Nausea |
2.9% |
Neurofibromatosis |
2.9% |
Respiratory Arrest |
2.9% |
Stupor |
2.9% |
Abortion Induced |
1.4% |
Aggression |
1.4% |
Brain Neoplasm Malignant |
1.4% |
Breast Cancer |
1.4% |
|
Secondary |
Depression |
39.5% |
Drug Use For Unknown Indication |
13.2% |
Product Used For Unknown Indication |
13.2% |
Anxiety Disorder |
5.3% |
Atrial Fibrillation |
5.3% |
Essential Hypertension |
5.3% |
Asphyxia |
2.6% |
Breast Cancer |
2.6% |
Constipation |
2.6% |
Gastric Disorder |
2.6% |
Nervousness |
2.6% |
Pain |
2.6% |
Weight Decreased |
2.6% |
|
Weight Increased |
17.6% |
Pancreatitis |
11.8% |
Unevaluable Event |
11.8% |
Asthma |
5.9% |
Dehydration |
5.9% |
Lethargy |
5.9% |
Paraesthesia |
5.9% |
Psychotic Disorder |
5.9% |
Serotonin Syndrome |
5.9% |
Tremor |
5.9% |
Vomiting |
5.9% |
Weight Decreased |
5.9% |
Withdrawal Syndrome |
5.9% |
|
Concomitant |
Drug Use For Unknown Indication |
30.6% |
Depression |
11.8% |
Hypertension |
8.8% |
Anxiety |
6.1% |
Gastrooesophageal Reflux Disease |
4.7% |
Insomnia |
4.4% |
Crohn's Disease |
3.4% |
Glioblastoma Multiforme |
3.4% |
Hypercholesterolaemia |
3.4% |
Panic Disorder |
3.4% |
Malignant Melanoma |
2.7% |
Prostate Cancer |
2.4% |
Contraception |
2.0% |
Ear Infection |
2.0% |
Pain |
2.0% |
Parkinson's Disease |
2.0% |
Sedation |
2.0% |
Asthma |
1.7% |
Localised Infection |
1.7% |
Skin Wrinkling |
1.7% |
|
Vomiting |
12.1% |
Upper Limb Fracture |
10.6% |
Urinary Incontinence |
10.6% |
Vaginal Haemorrhage |
9.1% |
Tinnitus |
7.6% |
Fracture |
4.5% |
Glioblastoma Multiforme |
4.5% |
Major Depression |
4.5% |
Cerebral Infarction |
3.0% |
Hypoaesthesia |
3.0% |
Neuropathy Peripheral |
3.0% |
Pain |
3.0% |
Pain In Extremity |
3.0% |
Protein Total Decreased |
3.0% |
Pruritus |
3.0% |
Schizophrenia |
3.0% |
Sensation Of Heaviness |
3.0% |
Serotonin Syndrome |
3.0% |
Therapeutic Procedure |
3.0% |
Tuberculosis |
3.0% |
|
Interacting |
Drug Use For Unknown Indication |
100.0% |
|
Wrist Fracture |
50.0% |
Personality Change |
25.0% |
White Blood Cell Count Decreased |
25.0% |
|